ES2290074T3
(es)
|
1993-07-19 |
2008-02-16 |
Angiotech Pharmaceuticals, Inc. |
Composiciones anti-angiogenicas que contienen taxol y un vehiculo no biodegradable y su uso.
|
FR2714053B1
(fr)
*
|
1993-12-22 |
1996-03-08 |
Pf Medicament |
Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
|
CN1112433A
(zh)
*
|
1994-05-24 |
1995-11-29 |
郭明 |
红豆杉属植物提取物及其应用
|
CA2178541C
(en)
|
1995-06-07 |
2009-11-24 |
Neal E. Fearnot |
Implantable medical device
|
FR2736355B1
(fr)
*
|
1995-07-07 |
1997-11-07 |
Pf Medicament |
Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii
|
US5965752A
(en)
*
|
1996-08-23 |
1999-10-12 |
Institut National De La Recherche Scientifique |
Preparative scale isolation and purification of taxanes
|
ES2195378T3
(es)
|
1997-08-21 |
2003-12-01 |
Univ Florida State |
Procedimiento para la sintesis de taxanos.
|
US6066748A
(en)
*
|
1997-12-17 |
2000-05-23 |
Han; Man Woo |
Process of extracting TAXOL® from taxus cuspidata
|
PT1068192E
(pt)
*
|
1998-01-14 |
2002-11-29 |
Bristol Myers Squibb Co |
Novos complexos cristalinos de bacatina iii com imidazol 2-metilimidazol ou isopropanol
|
US6136989A
(en)
*
|
1998-12-30 |
2000-10-24 |
Phytogen Life Sciences, Incorporated |
Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
|
US5969165A
(en)
*
|
1999-01-07 |
1999-10-19 |
508037 (Nb) Inc. |
Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
|
US6495705B2
(en)
|
2000-03-16 |
2002-12-17 |
Napro Biotherapeutics, Inc. |
Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
|
US6281368B1
(en)
|
2000-03-16 |
2001-08-28 |
Napro Biotherapeutics, Inc. |
Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
|
CA2307393A1
(en)
|
2000-05-01 |
2001-11-01 |
The University Of British Columbia |
Ginsenoside chemotherapy
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
CA2440935A1
(en)
|
2001-03-13 |
2002-09-19 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
EP1392254B1
(en)
*
|
2001-04-20 |
2007-06-06 |
The University of British Columbia |
Micellar drug delivery systems for hydrophobic drugs
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
EP1594459B1
(en)
|
2002-12-30 |
2010-02-17 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
AU2003303565A1
(en)
*
|
2002-12-31 |
2004-07-29 |
Natural Pharmaceuticals Inc. |
Pelletizing yew biomass for extraction of taxanes and other natural products
|
CA2525647A1
(en)
|
2003-05-16 |
2005-02-24 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
US8770459B2
(en)
*
|
2003-10-17 |
2014-07-08 |
Covidien Lp |
Surgical stapling device with independent tip rotation
|
US7407973B2
(en)
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US20060127510A1
(en)
*
|
2003-12-30 |
2006-06-15 |
Natural Pharmaceuticals, Inc. |
Harvesting and pelletizing yew biomass for extraction of taxanes and other natural products
|
US8003122B2
(en)
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US7846940B2
(en)
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US20050250954A1
(en)
*
|
2004-05-04 |
2005-11-10 |
Phytogen Life Sciences Inc. |
Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
|
US20050240036A1
(en)
*
|
2004-04-23 |
2005-10-27 |
Phytogen Life Sciences Inc. |
Semi-synthesis of taxane intermediates from a mixture of taxanes
|
US20050272807A1
(en)
*
|
2004-06-04 |
2005-12-08 |
Phytogen Life Sciences Inc. |
Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
|
KR20070045219A
(ko)
*
|
2004-07-02 |
2007-05-02 |
아이박스 파마슈티컬스 에스.알.오. |
파클리탁셀과 세팔로마닌의 분리 방법
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
WO2006089218A2
(en)
|
2005-02-17 |
2006-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for modulating angiogenesis
|
WO2007045093A1
(en)
*
|
2005-10-21 |
2007-04-26 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service |
Preparation of taxanes
|
WO2007107305A2
(en)
|
2006-03-22 |
2007-09-27 |
Medigene Ag |
Treatment of triple receptor negative breast cancer
|
WO2008005284A2
(en)
|
2006-06-30 |
2008-01-10 |
Cook Incorporated |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
CN100404520C
(zh)
*
|
2006-08-15 |
2008-07-23 |
北京诺瑞医药技术有限公司 |
从欧洲红豆杉枝叶中提取分离10-去乙酰基巴卡汀ⅲ的方法
|
CN101230053B
(zh)
*
|
2007-12-04 |
2010-06-02 |
北京诺瑞医药技术有限公司 |
从红豆杉枝叶中超声提取分离10-去乙酰基巴卡汀ⅲ的方法
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8273404B2
(en)
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
EP2859916B1
(en)
|
2008-05-22 |
2017-11-29 |
Galera Labs, LLC |
Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy
|
WO2010005850A1
(en)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Methods and compositions for modulating angiogenesis
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
EP2760848B1
(en)
|
2011-09-26 |
2018-11-28 |
Fresenius Kabi Oncology Limited |
Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
EP3539563A1
(en)
|
2012-07-19 |
2019-09-18 |
Redwood Bioscience, Inc. |
Antibody specific for cd22 and methods of use thereof
|
AU2013341711A1
(en)
|
2012-11-12 |
2015-05-21 |
Redwood Bioscience, Inc. |
Compounds and methods for producing a conjugate
|
LT2956175T
(lt)
|
2013-02-15 |
2017-12-11 |
The Regents Of The University Of California |
Chimerinis antigeno receptorius ir jo panaudojimo būdai
|
CN105358531B
(zh)
|
2013-03-14 |
2017-11-14 |
利兰-斯坦福大学初级学院的董事会 |
线粒体醛脱氢酶‑2调节剂和其使用方法
|
CN103508984B
(zh)
*
|
2013-10-22 |
2017-03-08 |
北京诺瑞医药技术有限公司 |
连续浸漉吸附富集法从红豆杉中提取10-dab的方法
|
JP6745218B2
(ja)
|
2013-11-27 |
2020-08-26 |
レッドウッド バイオサイエンス, インコーポレイテッド |
ヒドラジニル−ピロロ化合物及び複合体を生成するための方法
|
WO2015127137A1
(en)
|
2014-02-19 |
2015-08-27 |
Aldea Pharmaceuticals, Inc. |
Mitochondrial aldehyde dehydrogenase 2 (aldh2) binding polycyclic amides and their use for the treatment of cancer
|
US10517961B2
(en)
|
2015-09-25 |
2019-12-31 |
ZY Therapeutics, Inc. |
Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
|
US10654875B2
(en)
|
2015-11-12 |
2020-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
HUP1500603A2
(en)
*
|
2015-12-11 |
2017-06-28 |
Rotachrom Tech Kft |
Process for the separation of 10-deacetyl baccatin iii
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール.ピー.シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
UA123020C2
(uk)
|
2016-06-01 |
2021-02-03 |
Сервьє Айпі Юкей Лімітед |
Склади поліалкіленоксид-аспарагінази та способи їхнього виготовлення й використання
|
CN106397371A
(zh)
*
|
2016-08-31 |
2017-02-15 |
重庆市碚圣医药科技股份有限公司 |
一种用曼地亚红豆杉高产10‑dabⅲ的方法
|
TWI852903B
(zh)
|
2017-01-05 |
2024-08-21 |
杏國新藥股份有限公司 |
胰臟癌治療
|
SG11201906468TA
(en)
|
2017-01-18 |
2019-08-27 |
F1 Oncology Inc |
Chimeric antigen receptors against axl or ror2 and methods of use thereof
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
WO2018218004A1
(en)
|
2017-05-24 |
2018-11-29 |
The Board Of Regents Of The University Of Texas System |
Linkers for antibody drug conjugates
|
EA202091832A1
(ru)
|
2018-01-31 |
2021-01-11 |
ГАЛЕРА ЛЭБЗ, ЭлЭлСи |
Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины
|
BR112020020930A2
(pt)
|
2018-04-11 |
2021-03-02 |
Ohio State Innovation Foundation |
composição de liberação de fármaco, método para tratar um distúrbio oftalmológico e kit
|
US11897928B2
(en)
|
2018-07-18 |
2024-02-13 |
Manzanita Pharmaceuticals, Inc. |
Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
|
US11529402B2
(en)
|
2019-01-14 |
2022-12-20 |
Ignite Immunotherapy, Inc. |
Recombinant vaccinia virus and methods of use thereof
|
US11685904B2
(en)
|
2019-02-14 |
2023-06-27 |
Ignite Immunotherapy, Inc. |
Recombinant vaccinia virus and methods of use thereof
|
BR112021019701A2
(pt)
|
2019-04-02 |
2021-12-14 |
Kenjockety Biotechnology Inc |
Anticorpos multiespecíficos para antígeno de câncer de bomba de efluxo e composições, reagentes, kits e métodos relacionados aos mesmos
|
CA3163805A1
(en)
|
2019-12-12 |
2021-06-17 |
Ignite Immunotherapy, Inc. |
Variant oncolytic vaccinia virus and methods of use thereof
|
CA3164608A1
(en)
|
2020-01-29 |
2021-08-05 |
Kenjockety Biotechnology, Inc. |
Anti-mdr1 antibodies and uses thereof
|
US20230212305A1
(en)
|
2020-06-04 |
2023-07-06 |
Kenjockety Biotechnology, Inc. |
Anti-abcg2 antibodies and uses thereof
|
WO2021247423A1
(en)
|
2020-06-04 |
2021-12-09 |
Kenjockety Biotechnology, Inc. |
Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
CA3189291A1
(en)
|
2020-07-14 |
2022-01-20 |
Pfizer Inc. |
Recombinant vaccinia virus
|
CN116490522A
(zh)
|
2020-09-02 |
2023-07-25 |
肯乔克蒂生物技术股份有限公司 |
抗abcc1抗体及其应用
|
US20240010747A1
(en)
|
2020-11-13 |
2024-01-11 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
JP2023551203A
(ja)
|
2020-11-20 |
2023-12-07 |
アール.ピー.シェーラー テクノロジーズ、エルエルシー |
抗体-薬物コンジュゲートのためのグリコシド二重切断リンカー
|
CN112694458A
(zh)
*
|
2020-12-29 |
2021-04-23 |
重庆臻源红豆杉发展有限公司 |
一种10-去乙酰基巴卡亭ⅲ提取纯化方法
|
AU2022413942A1
(en)
|
2021-12-13 |
2024-05-30 |
William Robert Arathoon Living Trust Dated August 29, 2016 |
Anti-abcb1 antibodies
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|